Topic Hub
3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 3 of 3 clinical reviews.
A physician- and pharmacist-level guide to the siRNA lipid therapeutics drug class, focusing on inclisiran's monitoring bundle, dosing schedule, safety labs, and prescribing requirements per current ACC/AHA and FDA guidance.
Read clinical reviewA prescriber- and pharmacist-level monograph on the siRNA lipid therapeutics drug class, covering mechanism, pharmacokinetics, clinical trial data, dosing, safety, and place in therapy for LDL-C reduction.
Read clinical reviewClinician-focused review of siRNA lipid therapeutics (inclisiran) across special populations including renal impairment, hepatic impairment, elderly patients, and pregnancy. Dosing adjustments, monitoring, and evidence gaps.
Read clinical review